Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$51.7K Buy
171
+1
+0.6% +$199 0.01% 462
2026
Q1
$25.2K Hold
170
﹤0.01% 534
2025
Q4
$20.8K Hold
170
﹤0.01% 572
2025
Q3
$18.5K Hold
170
﹤0.01% 591
2025
Q2
$15.3K Hold
170
﹤0.01% 588
2025
Q1
$11.6K Hold
170
﹤0.01% 617
2024
Q4
$10.8K Hold
170
﹤0.01% 638
2024
Q3
$13.2K Buy
170
+20
+13% +$1.57K ﹤0.01% 610
2024
Q2
$12.4K Hold
150
﹤0.01% 605
2024
Q1
$10.5K Hold
150
﹤0.01% 648
2023
Q4
$8.75K Hold
150
﹤0.01% 658
2023
Q3
$6.9K Sell
150
-10
-6% -$480 ﹤0.01% 683
2023
Q2
$7.29K Buy
160
+10
+7% +$418 ﹤0.01% 682
2023
Q1
$6K Hold
150
﹤0.01% 692
2022
Q4
$5.66K Sell
150
-10
-6% -$349 ﹤0.01% 695
2022
Q3
$4.84K Buy
160
+120
+300% +$4.16K ﹤0.01% 711
2022
Q2
$1.28K Hold
40
﹤0.01% 882
2022
Q1
$1.46K Hold
40
﹤0.01% 846
2021
Q4
$1.72K Buy
+40
New +$1.54K ﹤0.01% 819
2020
Q3
Sell
-20
Closed -$389 946
2020
Q2
$389 Sell
20
-10
-33% -$171 ﹤0.01% 871
2020
Q1
$431 Sell
30
-180
-86% -$2.9K ﹤0.01% 788
2019
Q4
$3.74K Hold
210
﹤0.01% 738
2019
Q3
$3.35K Sell
210
-140
-40% -$1.96K ﹤0.01% 678
2019
Q2
$4.14K Buy
+350
New +$4.05K ﹤0.01% 646

Other funds holding KLAC

Glen Eagle Advisors's KLAC Position: Q2 2026 in Review

Glen Eagle Advisors increased its KLA (KLAC) stake by 0.59% in Q2 2026, buying an estimated $199 and bringing the position to 171 shares worth $51.7K. The position accounts for 0.01% of the portfolio, ranked #462.

Glen Eagle Advisors first reported a position in KLAC in Q2 2019 and has held it in 24 quarters since. 2,485 funds tracked by Wall St. Rank hold KLAC as of Q2 2026.

  • Glen Eagle Advisors held 171 shares of KLA worth $51.7K as of Q2 2026.
  • Glen Eagle Advisors bought 1 KLA share in Q2 2026, an estimated $199.
  • KLA made up 0.01% of Glen Eagle Advisors's portfolio in Q2 2026, its #462 holding.
  • Glen Eagle Advisors first reported a position in KLA in Q2 2019 and has held it in 24 quarters since.
  • 2,485 funds tracked by Wall St. Rank held KLA as of Q2 2026.

Based on Glen Eagle Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.